Stopped: Study withdrawn prior to enrollment due to lack of funding.
Developing technologies to help measure and provide tools to support medication-taking behaviors (medication adherence) is an important step to ending the human immunodeficiency virus (HIV) epidemic. TruTag Technologies has pioneered the use of a microparticle system that can be incorporated into the coating of medications may help users both identify the medication they are taking and record adherence events. By using a standard smartphone camera, shining light on TruTag-coated medications automatically identifies them to an onboard smartphone app which then indirectly records the adherence event. This study evaluates the real-world usability and feasibility of operating this system among people living with HIV (PLWH).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility of TruTag to Measure Antiretroviral (ART) Adherence
Timeframe: 30, 60, 90 days
Acceptability of TruTag, via System Usability Scale
Timeframe: 90 days
Acceptability of TruTag, via Qualitative Interviews
Timeframe: 90 days